[1]
|
The complement system in preeclampsia: a review of its activation and endothelial injury in the triad of COVID-19 infection and HIV-associated preeclampsia
Obstetrics & Gynecology Science,
2023
DOI:10.5468/ogs.22175
|
|
|
[2]
|
Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections
International Journal of Molecular Sciences,
2022
DOI:10.3390/ijms232213752
|
|
|
[3]
|
A Narrative Review of the Renin-Angiotensin-Aldosterone System in the Placenta and Placental Bed of HIV Infected Women of African Ancestry with Preeclampsia
Current Hypertension Reports,
2021
DOI:10.1007/s11906-021-01158-1
|
|
|
[4]
|
The Involvement of MicroRNAs in SARS-CoV-2 Infection Comorbid with HIV-Associated Preeclampsia
Current Hypertension Reports,
2021
DOI:10.1007/s11906-021-01138-5
|
|
|
[5]
|
A Narrative Review of the Renin-Angiotensin-Aldosterone System in the Placenta and Placental Bed of HIV Infected Women of African Ancestry with Preeclampsia
Current Hypertension Reports,
2021
DOI:10.1007/s11906-021-01158-1
|
|
|
[6]
|
The Role of Highly Active Antiretroviral Therapy (HAART) on Interleukin 17A (IL-17A) in Normotensive and Preeclamptic Black South African Women
Infectious Diseases in Obstetrics and Gynecology,
2020
DOI:10.1155/2020/3417632
|
|
|
[7]
|
HLA-G Polymorphisms Associated with HIV Infection and Preeclampsia in South Africans of African Ancestry
BioMed Research International,
2020
DOI:10.1155/2020/1697657
|
|
|
[8]
|
The role of the complement system in HIV infection and preeclampsia
Inflammation Research,
2019
DOI:10.1007/s00011-019-01240-0
|
|
|
[9]
|
Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: A systematic review
Pregnancy Hypertension,
2019
DOI:10.1016/j.preghy.2019.05.015
|
|
|
[10]
|
Human Immunodeficiency Virus and risk of pre-eclampsia and eclampsia in pregnant women: A meta-analysis on cohort studies
Pregnancy Hypertension,
2019
DOI:10.1016/j.preghy.2019.07.008
|
|
|
[11]
|
A Review of Angiogenic Imbalance in HIV-Infected Hypertensive Disorders of Pregnancy
Current Hypertension Reports,
2019
DOI:10.1007/s11906-019-0970-7
|
|
|
[12]
|
Human Immunodeficiency Virus and risk of pre-eclampsia and eclampsia in pregnant women: A meta-analysis on cohort studies
Pregnancy Hypertension,
2019
DOI:10.1016/j.preghy.2019.07.008
|
|
|
[13]
|
Pre-eclampsia: the role of highly active antiretroviral therapy and immune markers
Inflammation Research,
2018
DOI:10.1007/s00011-018-1190-3
|
|
|
[14]
|
Urinary clusterin and glutathione-s-transferase levels in HIV positive normotensive and preeclamptic pregnancies
Hypertension in Pregnancy,
2018
DOI:10.1080/10641955.2018.1498881
|
|
|
[15]
|
Urinary clusterin and glutathione-s-transferase levels in HIV positive normotensive and preeclamptic pregnancies
Hypertension in Pregnancy,
2018
DOI:10.1080/10641955.2018.1498881
|
|
|
[16]
|
Effect of vascular endothelial growth factors A, C, and D in HIV-associated pre-eclampsia
Hypertension in Pregnancy,
2017
DOI:10.1080/10641955.2017.1297821
|
|
|
[17]
|
Human infectious diseases and risk of preeclampsia: an updated review of the literature
Infection,
2017
DOI:10.1007/s15010-017-1031-2
|
|
|
[18]
|
Lymphatic vascular endothelial hyaluronan receptor-1 immunoexpression in placenta of HIV infected pre-eclamptic women
Journal of Reproductive Immunology,
2016
DOI:10.1016/j.jri.2016.06.010
|
|
|